Первая клетка. И чего стоит борьба с раком до последнего

Siegel R. L. et al. Cancer Statistics 2019. CA. 69, no. 1 (2019): 7–34.

Cancer Death Rates Vary Greatly Among US Counties. American Cancer Society. www.cancer.org/latest-news/cancer-death-rates-vary-greatly-among-us-counties.html

Mokdad A. H. et al. Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980–2014. JAMA. 317, no. 4 (2017): 388–406.

Maeda H., Khatami M. Analyses of Repeated Failures in Cancer Therapy for Solid Tumors: Poor Tumor-Selective Drug Delivery, Low Therapeutic Efficacy and Unsustainable Costs. Clinical and Translational Medicine. 7, no. 1 (2018): 11.

Fojo T., Grady C. How Much Is Life Worth: Cetuximab, Non-Small Cell Lung Cancer, and the $ 440 Billion Question. Journal of the National Cancer Institute. 101, no. 15 (2009): 1044–1049.

Kantarjian Hagop M. et al. Cancer Research in the United States: A Critical Review of Current Status and Proposal for Alternative Models. Cancer. 124, no. 14 (2018): 2881–2889.

Carrera P. M. et al. The Financial Burden and Distress of Patients with Cancer: Understanding and Stepping-Up Action on the Financial Toxicity of Cancer Treatment. CA, January 16, 2018. doi:10.3322/caac.21443.

Fojo T. et al. Unintended Consequences of Expensive Cancer Therapeutics – The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity: The John Conley Lecture. JAMA Otolaryngology – Head & Neck Surgery. 140, no. 12 (2014): 1225–1236.

Krummel M. F., Allison J. P. CD28 and CTLA-4 Have Opposing Effects on the Response of T Cells to Stimulation. Journal of Experimental Medicine. 182, no. 2 (1995): 459–465.

Davis D. M. The Rise of Cancer Immunotherapy: How Jim Allison Saved a Whole World. Nautilus, October 25, 2018.

Hutchinson L., Kirk R. High Drug Attrition Rates – Where Are We Going Wrong? Nature Reviews Clinical Oncology. 8, no. 4 (2011): 189–190.

Begley G. C., Ellis L. M. Raise Standards for Preclinical Cancer Research. Nature. 483 (2012): 531–533.

Johnson G. The Cancer Chronicles: Unlocking Medicine’s Deepest Mystery. New York: Alfred A. Knopf, 2013.

Yong Ed. How to Fight Cancer When Cancer Fights Back. Atlantic, April 26, 2017.

Gilligan A. M. Death or Debt? National Estimates of Financial Toxicity in Persons with Newly-Diagnosed Cancer. American Journal of Medicine. 131, no. 10 (2018): 1187–1199.

Baker M. 1,500 Scientists Lift the Lid on Reproducibility: Survey Sheds Light on the “Crisis” Rocking Research. Nature. 533 (2016): 452–454.

Cohen J. D. et al. Combined Circulating Tumor DNA and Protein Biomarker-Based Liquid Biopsy for the Earlier Detection of Pancreatic Cancers. PNAS. 114, no. 38 (2017): 10202–10207.

Wang Y. et al. Detection of Tumor-Derived DNA in Cerebrospinal Fluid of Patients with Primary Tumors of the Brain and Spinal Cord. PNAS. 112, no. 31 (2015): 9704–9709.

Bettegowda C. Detection of Circulating Tumor DNA in Early – and Late-Stage Human Malignancies. Science Translational Medicine. 6, no. 224 (2014): 224ra24.

Vogelstein B. et al. Cancer Genome Landscapes. Science. 339, no. 6127 (2013): 1546–1558.